141 related articles for article (PubMed ID: 12208613)
1. Incorporating phenotype-dependent growth rates into the color-shift model for preneoplastic hepatocellular lesions.
Burkholder I; Kopp-Schneider A
Math Biosci; 2002; 179(2):145-60. PubMed ID: 12208613
[TBL] [Abstract][Full Text] [Related]
2. A model for hepatocarcinogenesis treating phenotypical changes in focal hepatocellular lesions as epigenetic events.
Kopp-Schneider A; Portier C; Bannasch P
Math Biosci; 1998 Mar; 148(2):181-204. PubMed ID: 9610106
[TBL] [Abstract][Full Text] [Related]
3. A model for hepatocarcinogenesis with clonal expansion of three successive phenotypes of preneoplastic cells.
Geisler I; Kopp-Schneider A
Math Biosci; 2000 Dec; 168(2):167-85. PubMed ID: 11121564
[TBL] [Abstract][Full Text] [Related]
4. Application of a color-shift model with heterogeneous growth to a rat hepatocarcinogenesis experiment.
Groos J; Kopp-Schneider A
Math Biosci; 2006 Aug; 202(2):248-68. PubMed ID: 16603206
[TBL] [Abstract][Full Text] [Related]
5. [Sequential cellular and molecular changes during hepatocarcinogenesis].
Bannasch P
Verh Dtsch Ges Pathol; 1995; 79():72-83. PubMed ID: 8600697
[TBL] [Abstract][Full Text] [Related]
6. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
[TBL] [Abstract][Full Text] [Related]
7. [Molecular and metabolic changes in human clear cell liver foci].
Ribback S; Calvisi DF; Cigliano A; Rausch J; Heidecke CD; Birth M; Dombrowski F
Pathologe; 2015 Nov; 36 Suppl 2():210-5. PubMed ID: 26483250
[TBL] [Abstract][Full Text] [Related]
8. Differential staining of preneoplastic foci in rat liver parenchyma during azo dye carcinogenesis.
Brière N
Histochemie; 1971; 26(2):113-9. PubMed ID: 4104416
[No Abstract] [Full Text] [Related]
9. Application of a two-phenotype color-shift model with heterogeneous growth to a rat hepatocarcinogenesis experiment.
Groos J; Kopp-Schneider A
Math Biosci; 2010 Apr; 224(2):95-100. PubMed ID: 20043929
[TBL] [Abstract][Full Text] [Related]
10. Neoplastic progression in experimental hepatocarcinogenesis.
Scherer E
Biochim Biophys Acta; 1984; 738(4):219-36. PubMed ID: 6394049
[TBL] [Abstract][Full Text] [Related]
11. The role of growth of normal and preneoplastic cell populations for tumor promotion in rat liver.
Schulte-Hermann R; Schuppler J; Timmermann-Trosiener I; Ohde G; Bursch W; Berger H
Environ Health Perspect; 1983 Apr; 50():185-94. PubMed ID: 6873013
[TBL] [Abstract][Full Text] [Related]
12. Clear cell hepatocellular carcinoma: origin, metabolic traits and fate of glycogenotic clear and ground glass cells.
Bannasch P; Ribback S; Su Q; Mayer D
Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):570-594. PubMed ID: 29291777
[TBL] [Abstract][Full Text] [Related]
13. Xenomorphic hepatocellular precursors and neoplastic progression of tigroid cell foci induced in rats with low doses of N-nitrosomorpholine.
Ströbel P; Klimek F; Zerban H; Kopp-Schneider A; Bannasch P
Carcinogenesis; 1998 Dec; 19(12):2069-80. PubMed ID: 9886559
[TBL] [Abstract][Full Text] [Related]
14. Involvement of multiple cell cycle aberrations in early preneoplastic liver cell lesions by tumor promotion with thioacetamide in a two-stage rat hepatocarcinogenesis model.
Kimura M; Fujii Y; Yamamoto R; Yafune A; Hayashi SM; Suzuki K; Shibutani M
Exp Toxicol Pathol; 2013 Nov; 65(7-8):979-88. PubMed ID: 23474136
[TBL] [Abstract][Full Text] [Related]
15. Cell biology of hepatocarcinogenesis.
Saeter G; Seglen PO
Crit Rev Oncog; 1990; 1(4):437-66. PubMed ID: 1964598
[No Abstract] [Full Text] [Related]
16. Cell proliferation and apoptosis in normal liver and preneoplastic foci.
Schulte-Hermann R; Bursch W; Kraupp-Grasl B; Oberhammer F; Wagner A; Jirtle R
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):87-90. PubMed ID: 8013429
[TBL] [Abstract][Full Text] [Related]
17. An origin of presumptive preneoplastic foci and nodules from hepatocytes in chemical carcinogenesis in rat liver.
Gindi T; Ghazarian DM; Deitch D; Farber E
Cancer Lett; 1994 Aug; 83(1-2):75-80. PubMed ID: 8062236
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathology of early stage chemically induced hepatocarcinogenesis.
Ogawa K
Pathol Int; 2009 Sep; 59(9):605-22. PubMed ID: 19712128
[TBL] [Abstract][Full Text] [Related]
19. Biochemical markers associated with the stages of promotion and progression during hepatocarcinogenesis in the rat.
Pitot HC; Dragan Y; Sargent L; Xu YH
Environ Health Perspect; 1991 Jun; 93():181-9. PubMed ID: 1723043
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis.
Kowalik MA; Sulas P; Ledda-Columbano GM; Giordano S; Columbano A; Perra A
Oncotarget; 2015 Nov; 6(36):38749-63. PubMed ID: 26452031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
